Opioid Use Disorder at APNA 40th Annual Conference

Lecture · Addictions/Substance Use

Medetomidine in the Fentanyl Era: Emergence of a Veterinary Sedative as a Novel Adulterant

Deborah Salani · Beatriz Valdes · Deana Goldin

Overview of medetomidine appearing as an adulterant in the fentanyl supply, its potency, and implications for overdose management. Pharmacology-eligible.

Drug Interactions & Safety · Substance Use Disorders

Workshop · Practice

Finding Balance: Stabilization Through MOUD

Kayla Cross

Covers combining buprenorphine-based medication for opioid use disorder with harm-reduction approaches to stabilize patients. Pharmacology-eligible.

Workshop · Addictions/Substance Use

Rethinking Risk: Harm Reduction as Essential Psychiatric Nursing Practice

Kayla Cross

Positions harm reduction as core nursing practice, drawing on a year-long collaborative program serving high-risk communities.

Substance Use Disorders

Lecture · Addictions

Evaluating the Efficacy of a Standardized Buprenorphine Induction Protocol to Reduce Precipitated Withdrawal in Emergency Department Patients with Opioid Withdrawal

Marcus Boutte

Evidence for standardized ED buprenorphine induction protocols that lower precipitated-withdrawal risk and improve engagement.

Emergency & Acute Psychiatry

Lecture · Addictions

Buprenorphine in the Fentanyl Era: Emerging Evidence and Experiences From the Front Lines

Mark Crawford · Kevin Paschall

Low-barrier buprenorphine strategies adapted to how fentanyl has changed opioid use disorder treatment. Pharmacology-eligible.